Atlas Trials

Investigation of Contralateral Arytenoid Sparing IMRT for T1a & T2a Larynx Cancer & Analysis of Post-treatment Laryngeal Function

Clinical trial NCT02633540 · TERMINATED

Trial details

NCT number
NCT02633540
Sponsor
Fox Chase Cancer Center
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Laryngeal Neoplasms
Start date
2015-11-16
Primary completion
2017-10-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.